Evolent Health, Inc (EVH): Price and Financial Metrics


Evolent Health, Inc (EVH): $29.43

0.47 (+1.62%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

EVH POWR Grades


  • EVH scores best on the Growth dimension, with a Growth rank ahead of 99.8% of US stocks.
  • The strongest trend for EVH is in Growth, which has been heading up over the past 179 days.
  • EVH ranks lowest in Value; there it ranks in the 28th percentile.

EVH Stock Summary

  • The price/operating cash flow metric for Evolent Health Inc is higher than 93.25% of stocks in our set with a positive cash flow.
  • With a year-over-year growth in debt of -22.05%, Evolent Health Inc's debt growth rate surpasses only 18.24% of about US stocks.
  • As for revenue growth, note that EVH's revenue has grown -11.2% over the past 12 months; that beats the revenue growth of only 10.28% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to Evolent Health Inc, a group of peers worth examining would be IMAC, MEG, HLIO, HMTV, and MNSB.
  • EVH's SEC filings can be seen here. And to visit Evolent Health Inc's official web site, go to www.evolenthealth.com.

EVH Valuation Summary

  • In comparison to the median Technology stock, EVH's price/sales ratio is 59.63% lower, now standing at 2.2.
  • EVH's price/earnings ratio has moved up 3.2 over the prior 76 months.
  • Over the past 76 months, EVH's price/sales ratio has gone NA NA.

Below are key valuation metrics over time for EVH.

Stock Date P/S P/B P/E EV/EBIT
EVH 2021-09-01 2.2 3.5 -30.6 -54.1
EVH 2021-08-31 2.2 3.5 -30.2 -53.6
EVH 2021-08-30 2.2 3.5 -30.2 -53.4
EVH 2021-08-27 2.2 3.5 -30.0 -53.1
EVH 2021-08-26 2.1 3.4 -29.5 -52.2
EVH 2021-08-25 2.1 3.4 -29.4 -52.2

EVH Growth Metrics

    The 5 year price growth rate now stands at -32.61%.
  • Its 4 year cash and equivalents growth rate is now at -43.2%.
  • The 3 year price growth rate now stands at 6.92%.
Over the past 34 months, EVH's revenue has gone up $222,852,000.

The table below shows EVH's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 907.957 38.747 -37.601
2021-09-30 931.522 -40.76 -46.579
2021-06-30 973.644 -105.76 -70.887
2021-03-31 990.219 -43.847 -265.301
2020-12-31 1,022.433 -16.225 -334.246
2020-09-30 987.035 9.813 -517.717

EVH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • EVH has a Quality Grade of D, ranking ahead of 14.15% of graded US stocks.
  • EVH's asset turnover comes in at 0.713 -- ranking 221st of 563 Business Services stocks.
  • EVOL, GLOB, and AKAM are the stocks whose asset turnover ratios are most correlated with EVH.

The table below shows EVH's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.713 0.254 -0.052
2021-06-30 0.726 0.244 -0.113
2021-03-31 0.742 0.245 -0.547
2020-12-31 0.746 0.228 -0.601
2020-09-30 0.704 0.220 -0.869
2020-06-30 0.636 0.223 -0.795

EVH Price Target

For more insight on analysts targets of EVH, see our EVH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $28.33 Average Broker Recommendation 1.43 (Moderate Buy)

EVH Stock Price Chart Interactive Chart >

Price chart for EVH

EVH Price/Volume Stats

Current price $29.43 52-week high $34.60
Prev. close $28.96 52-week low $18.33
Day low $28.43 Volume 719,000
Day high $29.85 Avg. volume 687,250
50-day MA $29.52 Dividend yield N/A
200-day MA $27.29 Market Cap 2.70B

Evolent Health, Inc (EVH) Company Bio


Evolent Health provides health-care delivery and payment solutions in the United States. The company was founded in 2011 and is based in Arlington, Virginia.


EVH Latest News Stream


Event/Time News Detail
Loading, please wait...

EVH Latest Social Stream


Loading social stream, please wait...

View Full EVH Social Stream

Latest EVH News From Around the Web

Below are the latest news stories about Evolent Health Inc that investors may wish to consider to help them evaluate EVH as an investment opportunity.

Why Shares of Evolent Health Jumped 22% Thursday

The company's stock climbed nearly $5 higher per share on Thursday over its closing price on Wednesday.

Yahoo | February 24, 2022

Evolent Health (EVH) Q4 2021 Earnings Call Transcript

Welcome to Evolent Health's earnings conference call for the fourth quarter and year ended December 31, 2021. Your host for the call today from Evolent Health are Seth Blackley, chief executive officer; and John Johnson, chief financial officer.

Yahoo | February 24, 2022

Evolent Health Announces Fourth Quarter and Full Year 2021 Results

Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced financial results for the quarter and full year ended December 31, 2021.

Yahoo | February 23, 2022

Zendesk (ZEN) Misses Q4 Earnings Estimates

Zendesk (ZEN) delivered earnings and revenue surprises of -11.11% and 1.59%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 10, 2022

Digital Turbine (APPS) Q3 Earnings and Revenues Surpass Estimates

Digital Turbine (APPS) delivered earnings and revenue surprises of 13.95% and 6.34%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 8, 2022

Read More 'EVH' Stories Here

EVH Price Returns

1-mo 0.96%
3-mo 26.20%
6-mo 3.12%
1-year 47.15%
3-year 102.97%
5-year 26.04%
YTD 6.36%
2021 72.61%
2020 77.13%
2019 -54.64%
2018 62.20%
2017 -16.89%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6016 seconds.